Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Helena HL Borba"'
Autor:
Seyed Moayed Alavian, Mohammad Tasavon Gholamhoseini, Heidar Sharafi, Helena HL Borba, Asma Sabermahani, Behzad Hajarizadeh
Publikováno v:
BMJ Open, Vol 12, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/b63067b4f98140f2ad32a158e9f3519f
Autor:
Mohammad Tasavon Gholamhoseini, Heidar Sharafi, Helena HL Borba, Seyed Moayed Alavian, Asma Sabermahani, Behzad Hajarizadeh
Publikováno v:
BMJ open. 12(6)
IntroductionLow-cost generic direct-acting antiviral (DAA) regimens for treatment of hepatitis C virus (HCV) are available in several low-income/middle-income countries, important for treatment scale-up. This study evaluated the cost-effectiveness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b0737b8735c00777f440c33bbbbc872
https://pubmed.ncbi.nlm.nih.gov/35676019
https://pubmed.ncbi.nlm.nih.gov/35676019
Autor:
Laiza M Steimbach, Helena Hl Borba, Roberto Pontarolo, Claudia Ivantes, Astrid Wiens, Maria La Pedroso, Fernando Fernandez-Llimos, Fernanda S. Tonin
Publikováno v:
Therapeutics and Clinical Risk Management
Helena HL Borba,1 Astrid Wiens,1 Laiza M Steimbach,1 Fernanda S Tonin,1 Maria LA Pedroso,2 Cláudia AP Ivantes,3 Fernando Fernandez-Llimos,4 Roberto Pontarolo1 1Pharmaceutical Sciences Postgraduate Research Program, Department of Pharmacy, 2Gastroent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f5923f8ac7d9d2872b5d93920e3f7a9
https://hdl.handle.net/10453/125322
https://hdl.handle.net/10453/125322
